Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 (Listing Regulations), Astec Lifesciences has informed that the Meeting of Board of Directors of Astec LifeSciences Limited is scheduled to be held on Friday, 28th July, 2017 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter ended 30th June, 2017 (subject to limited review by the Statutory Auditors of the Company), after these results are reviewed by the Audit Committee. In terms of Regulation 47 of the Listing Regulations, please find enclosed herewith copies of the Notice of the Board Meeting published in newspapers, viz. Business Standard (in English Language) and Mumbai Lakshadeep (in Marathi language) today, i.e., on 21st July, 2017.
The above information is a part of company’s filings submitted to BSE.
